Victor Chen
Overview
Explore the profile of Victor Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen J, Meglan A, Vaccaro K, Velarde J, Chen V, Ribeiro J, et al.
bioRxiv
. 2024 Dec;
PMID: 39651307
Macrophages hold tremendous promise as effectors of cancer immunotherapy, but the best strategies to provoke these cells to attack tumors remain unknown. Here, we evaluated the therapeutic potential of targeting...
2.
Colwell B, Aguilar J, Hughes F, Goriacko P, Chen V, Chang M, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Sep;
4(1):e127.
PMID: 39290625
Objective: Compare the real-world impact of fidaxomicin (FDX) and vancomycin (VAN) on infection (CDI) recurrence in a high-risk patient population. Design: A retrospective, matched-cohort study evaluating hospitalized patients with CDI...
3.
Gogoi M, Clark P, Ferreira A, Rodriguez Rodriguez N, Heycock M, Ko M, et al.
Nature
. 2024 Aug;
632(8026):885-892.
PMID: 39112698
Migration and homing of immune cells are critical for immune surveillance. Trafficking is mediated by combinations of adhesion and chemokine receptors that guide immune cells, in response to chemokine signals,...
4.
Bruneau B, Surdam K, Bland A, Krueger A, Wise A, Cotarlan A, et al.
Contemp Clin Trials Commun
. 2024 Aug;
40:101291.
PMID: 39105082
Background: This Site Feasibility Task Force convened to assess the complex and burdensome process of site feasibility in clinical trials. The objective was to create mutual understanding of challenges and...
5.
Balliu B, Douglas C, Seok D, Shenhav L, Wu Y, Chatzopoulou D, et al.
NPJ Digit Med
. 2024 Feb;
7(1):49.
PMID: 38418551
Over the last ten years, there has been considerable progress in using digital behavioral phenotypes, captured passively and continuously from smartphones and wearable devices, to infer depressive mood. However, most...
6.
Adel Ramawad H, Toloui A, Chen V, Sun Y
Qatar Med J
. 2024 Jan;
2023(4):36.
PMID: 38187991
The opioid crisis has become a significant public health concern in recent years. Although respiratory depression and overdose are the most reported side effects of fentanyl, there have been rare...
7.
Abraham D, Lichvar A, Brubaker A, Haste N, Chen V, Abeles S, et al.
Transpl Infect Dis
. 2023 Aug;
25(6):e14125.
PMID: 37594213
No abstract available.
8.
McSwain L, Pillsbury C, Haji-Seyed-Javadi R, Rath S, Chen V, Huang T, et al.
Sci Rep
. 2023 Jun;
13(1):9717.
PMID: 37322047
No abstract available.
9.
Zhao X, Stein K, Chen V, Griffin M, Lairson L, Hang H
Nat Chem Biol
. 2023 May;
19(10):1205-1214.
PMID: 37248411
The microbiota generates diverse metabolites to modulate host physiology and disease, but their protein targets and mechanisms of action have not been fully elucidated. To address this challenge, we explored...
10.
McSwain L, Pillsbury C, Haji-Seyed-Javadi R, Rath S, Chen V, Huang T, et al.
Sci Rep
. 2023 May;
13(1):8087.
PMID: 37208357
Y-box binding protein 1 (YBX1 or YB1) is a therapeutically relevant oncoprotein capable of RNA and DNA binding and mediating protein-protein interactions that drive proliferation, stemness, and resistance to platinum-based...